SlideShare ist ein Scribd-Unternehmen logo
1 von 23
Downloaden Sie, um offline zu lesen
Prof. Thanh N. Truong
University of Utah
Astonis LLC
Institute of Computational Science and Technology
The Drug Discovery Process
Drug Target
Identification

Target
Validation

Lead
Identification

Lead
Optimization

Pre-clinical &
Clinical
Development

It takes about 15 years and costs around 880 millions
USD, ~10,000 compounds (DiMasi et al. 2003;
Dickson & Gagnon 2004) to develop a new drug.

FDA Review
25,000

metabolite
Genomics Facts
Around 99% of our genes have counterparts in mice
Our genetic overlap with chimpanzees is about 97.5%
The genetic difference between one person and another is less than 0.1 %
But because only a few regions of DNA actively encode life functions, the
real difference between one person and another is only 0.0003 %

It is becoming increasingly evident that the complexity of
biological systems lies at the level of the proteins, and that
genomics alone will not suffice to understand these systems.
Structure-based Computer-Aided Drug Design
Drug Target
Identification

Target
Validation

Shorten development
time to Lead
Identification

Lead
Identification

Lead
Optimization

Known 3D structure
PDB databank

Pre-clinical &
Clinical
Development

FDA Review

Unknown 3D structure for the target protein

Homology modeling or
Protein Structure Prediction

Reduce cost

MD simulations

Past Successes
1.

2.

3.

HIV protease inhibitor
amprenavir (Agenerase)
from Vertex & GSK (Kim et
al. 1995)
HIV: nelfinavir (Viracept) by
Pfizer (& Agouron) (Greer et
al. 1994)
Influenza neuraminidase
inhibitor zanamivir
(Relenza) by GSK
(Schindler 2000)

Target Model
Docking
Simulation
Cluster
Analysis
Scoring

Analysis

Trajectories
Homology Modeling
Prediction of protein tertiary structure from the known sequence
Docking
The Problem:
Determine the optimal binding structure of a ligand (a drug
candidate, a small molecule) to a receptor (a drug target, a protein or
DNA) and quantify the strength of the ligand-receptor interaction.

1.
2.
3.
4.
5.

Where the ligand will bind?
How will it bind?
How strong?
Why?
What make a ligand binds
to the receptor better than
the others?
6. ????
The Challenge

Ligand and receptor are
conformational flexible.
Receptor may have more than
one possible binding site.
Weak short-range Interactions:
hydrogen bonds, salt bridges,
hydrophobic contacts,
electrostatics, van der Walls
repulsions
Surface
complementary.
Binding affinity is the difference to
the uncomplexed state – solvation
and desolvation play important
role.
Binding affinity describes an
ensemble of complexes not a
single one.

Orientation
of Ligand

Bound waters

Flexibility of residues in
the binding site

Large protein
conformation change
Binding Affinity
Association equilibrium constant

[ RL ]s
Ka =
[ R ]s [ L ]s

b
∆Gg

+
∆Gsolv ( R )

∆Gsolv ( L )

Free energy of binding:
b
∆Gs = ∆H − T ∆S = − RT ln K a
Enthalpy Entropy

+

From the thermodynamic cycle:
b
b
∆Gs = ∆Gg + ∆Gsolv ( RL ) − {∆Gsolv ( R ) + ∆Gsolv ( L )}

b
∆Gs

∆Gsolv ( RL )
Docking Process
Descriptions of the
receptor 3D structure,
binding site and ligand

Sampling of the
configuration space of
the binding complex
Multiple binding
configurations for a
single protein
structure and a ligand

Evaluating free energy
of binding for scoring

Local/global minimum

Ensemble of protein
structures and/or
multiple ligands
Description of Receptor 3D Structure
Known 3D protein structures from Protein Data Bank (PDB)
(http://www.rcsb.org/pdb)

Locations of hydrogen atoms, bound water molecules, and metal ions are either not
known or highly uncertain.
Identities and locations of some heavy atoms (e.g., ~1/6 of N/O of Asn & Gln, and N/C
of His incorrectly assigned in PDB; up to 0.5 Å uncertainty in position)
Conformational flexibility of proteins is not known

Homology models from highly similar sequences with known structures
Critical analysis of the receptor structure before docking is needed:
resolution, missing residues, bound waters and ions, protonation states, etc.
Descriptions of Binding Site
Known binding site – PDB
database has about 6000 proteinligand complexes
Atomistic based
o Receptor atomic coordinates and
location of a binding box

Descriptor based
o
o
o
o

Surface
Volume
Points & distances, bond vectors
grid and various properties such
as electrostatic potential,
hydrophobic moment, polar,
nonpolar, atom types, etc

Unknown binding site
Blind docking with the binding box
cover the entire receptor –
computationally expensive
Better method for finding potential
binding sites is needed
Ligand Chemical Space

National Cancer Institute (NCI) public database
(http://129.43.27.140/ncidb2/)
About 250 K 3D structures

ZINC public database (http://zinc.docking.org/)
About 8 million 3D structures

PubChem public database (http://pubchem.ncbi.nlm.nih.gov/)
About 19 million entries (but no 3D structures)

Cambridge Structure database (CSD)
About 3 million crystal structures

Chemical Abstract Service (CAS) and SciFinder
Several other smaller databases …

Atomic partial charges
from MM force fields
or MO calculations
must be added to
each molecule for
evaluation of the
score function
Different Approaches in Docking
Complete conformation and configuration space are too large. Different approaches were
developed for effective sampling of the receptor-ligand configuration space.

Automated

Manual

Descriptor Matching

Simulation-based

• Use pattern-recognizing
geometric methods to
match ligand and receptor
site descriptors
• Ligand flexibility is limited
• Receptor is rigid
• Accuracy is not very good
– not discriminative
• Fast

• Use simulation methods to
sample the local configuration
space: MC-Simulated
Annealing, Genetic Algorithm.
Must run an ensemble of
starting orientations for
accurate statistics
• Ligand and protein flexibility
can be considered
• Free energy of binding is
evaluated
• Accuracy is good
• Time consuming
• Grid map is often used to
speed up energy evaluations

User interactive force
feedbacks through
haptic devices

Focus
MC-Simulated Annealing Method
Randomly change the receptor flexible residues,
ligand position, orientation, and/or conformation
Evaluate the new energy, Enew

YES

Enew < Eold ?

NO

Accept the new move
with P = exp{-∆E/kbT}

Accept the new move
Enew
Eold
Reduce the temperature

NO

Naccept or reject > Nlimit
YES

Done
Genetic Algorithm
Darwin Theory of Evolution

Living organisms
Made up of cells
Has the same set of chromosomes (DNA)

Genome: A set of all chromosomes
Chromosome consists of genes

Genotype: A particular set of genes
Each gene encodes a protein (a trait)
Each gene has a location in the chromosome (locus)

Reproduction by cross-over and mutation
Genetic Algorithm for Docking
Gene 1

Gene 2

Gene 3

x1 y1 z1 φ1 ψ1 ω1 τ1 τ2 τ3 τ4
Position

Orientation

Chromosome 1

Torsional angles

x2 y2 z2 φ2 ψ2 ω2 τ1’ τ2’ τ3’ τ4’ Chromosome 2
A chromosome is a possible solution: binding position,
orientation, and values of all rotatable torsional angles
Fitness Test
Translates genotypes to phenotypes (receptor-ligand complex
structures) for binding free energy evaluation.

A cell is a set of
possible solutions,
i.e. chromosomes.
Typical population
= 100-200

Select best parents
Those with large negative ∆G binding

Generate new generation
Migration: Move the best genes to the next generation
Cross-over: Exchange a set of genes from one parent chromosome to another. Typical cross-over
rate = 80-90%
Mutation: Randomly change a value of a gene, i.e. position, orientation, or torsional values. Typical
mutation rate = 0.5-1%
Two-point Cross-over Operator

x1 y1 z1 φ1 ψ1 ω1 τ1 τ2 τ3 τ4

Parent 1

Swap positions

x2 y2 z2 φ2 ψ2 ω2 τ1’ τ2’ τ3’ τ4’ Parent 2
x2 y2 z2 φ1 ψ1 ω1 τ1 τ2 τ3 τ4

Child 1

x1 y1 z1 φ2 ψ2 ω2 τ1’ τ2’ τ3’ τ4’ Child 2
Lamarkian Genetic Algorithm -- AutoDock
Environmental adaptation of an individual’s phenotypic characteristics
acquired during lifetime can become heritable traits
Survival of the fittest.
1. Mutation and cross-breeding to
generate new genotype
generate
new possible ligand binding
configuration
2. Transfer to phenotype to evaluate
fitness
forming receptor-ligand
configuration.

Environmental
adaption

3. Adapt to the local environment to
improve fitness local minimization.
4. Transfer back to genotype for future
generations save the optimized
ligand binding configuration for future
generations.

Genetic Algorithm – Local Search

Morris et al., J. Comp. Chem. 1998, 19, 1639

Transfer to genotype
for future generations,
i.e. heritable traits.

GA

LS
Scoring Functions
Force Field based function

Focus
GOAL: Fast & Accurate
Experimentally observed complex

•Score = -∆Gbinding
•Has physical basis
•Fast with pre-computed grid
Multivariate regression fit physically
motivated structural functions to
experimentally known complexes
with measured binding affinity

-Score

Empirical function

Knowledge-based function
Statistical pair potential derived
from known complex structures

Descriptor based function
Based on chemical properties,
pharmacaphore, contact, shape
complementary

Complex configurations
Force Field Based Scoring Function
b
Score = −∆Gs
b
∆Gs = Cvdw ∗ ∆Gvdw + Cele ∗ ∆Gele + Chb ∗ ∆Ghb + Ctor ∗ ∆Gtor + Csolv ∗ ∆Gsolv

Coefficients are empirically determined using linear regression analysis from a set of
protein-ligand complexes from LPDB with known experimental binding constants.
Analyses
Energy histogram

Clustering analysis

Distribution of binding energies
average binding energy

Distribution of binding modes
different binding sites and ligand
binding orientations
Docking with Science Community Laboratory
Identify a target

Millions of molecules
from ZINC database
Docking simulation
with AutoDock-Vina

Rank according to
binding energy

Weitere ähnliche Inhalte

Was ist angesagt?

Molecular docking and_virtual_screening
Molecular docking and_virtual_screeningMolecular docking and_virtual_screening
Molecular docking and_virtual_screeningFlorent Barbault
 
Basics Of Molecular Docking
Basics Of Molecular DockingBasics Of Molecular Docking
Basics Of Molecular DockingSatarupa Deb
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)Pinky Vincent
 
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS santosh Kumbhar
 
Structure based drug designing
Structure based drug designingStructure based drug designing
Structure based drug designingSeenam Iftikhar
 
Molecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesMolecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesTheabhi.in
 
Virtual screening ppt
Virtual screening pptVirtual screening ppt
Virtual screening pptVivekYadav490
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Designbaoilleach
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureSaramita De Chakravarti
 
Structure Based Drug Design
Structure Based Drug DesignStructure Based Drug Design
Structure Based Drug Designnmicaelo
 
Pharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningPharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningSanchit Dhankhar
 
Structure Based Drug Design
Structure Based Drug DesignStructure Based Drug Design
Structure Based Drug Designdikheidi
 
Virtual screening strategies and applications
Virtual screening strategies and applicationsVirtual screening strategies and applications
Virtual screening strategies and applicationsAshishkumar3249
 

Was ist angesagt? (20)

Molecular docking and_virtual_screening
Molecular docking and_virtual_screeningMolecular docking and_virtual_screening
Molecular docking and_virtual_screening
 
CADD
CADDCADD
CADD
 
Docking
DockingDocking
Docking
 
Basics Of Molecular Docking
Basics Of Molecular DockingBasics Of Molecular Docking
Basics Of Molecular Docking
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
 
Structure based drug designing
Structure based drug designingStructure based drug designing
Structure based drug designing
 
Molecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesMolecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniques
 
Virtual screening ppt
Virtual screening pptVirtual screening ppt
Virtual screening ppt
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Design
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative Structure
 
De Novo Drug Design
De Novo Drug DesignDe Novo Drug Design
De Novo Drug Design
 
Structure Based Drug Design
Structure Based Drug DesignStructure Based Drug Design
Structure Based Drug Design
 
Pharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningPharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screening
 
Structure Based Drug Design
Structure Based Drug DesignStructure Based Drug Design
Structure Based Drug Design
 
Virtual screening strategies and applications
Virtual screening strategies and applicationsVirtual screening strategies and applications
Virtual screening strategies and applications
 
3d qsar
3d qsar3d qsar
3d qsar
 
MOLECULAR DOCKING
MOLECULAR DOCKINGMOLECULAR DOCKING
MOLECULAR DOCKING
 
CADD.pptx
CADD.pptxCADD.pptx
CADD.pptx
 
Denovo Drug Design
Denovo Drug DesignDenovo Drug Design
Denovo Drug Design
 

Andere mochten auch

Structure based drug design
Structure based drug designStructure based drug design
Structure based drug designADAM S
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designingMuhammed sadiq
 
Computer aided drug designing (CADD)
Computer aided drug designing (CADD)Computer aided drug designing (CADD)
Computer aided drug designing (CADD)Aakshay Subramaniam
 
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERYSTRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERYTHILAKAR MANI
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug designN K
 
structure based drug design of curcumin analogues
structure based drug design of curcumin analoguesstructure based drug design of curcumin analogues
structure based drug design of curcumin analoguesHafila Ashraf
 
Computer aided drug designing
Computer aided drug designing Computer aided drug designing
Computer aided drug designing Ayesha Aftab
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug designArchana Zala
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug designAli Ahsan
 
Computer Aided Drug Design and Discovery : An Overview (2006)
Computer Aided Drug Design and Discovery : An Overview (2006)Computer Aided Drug Design and Discovery : An Overview (2006)
Computer Aided Drug Design and Discovery : An Overview (2006)Girinath Pillai
 
Aiding Computer Aided Drug Design
Aiding Computer Aided Drug DesignAiding Computer Aided Drug Design
Aiding Computer Aided Drug DesignShahir Shamsir
 
Introduction to the drug discovery process
Introduction to the drug discovery processIntroduction to the drug discovery process
Introduction to the drug discovery processThanh Truong
 
The Many Roles of Computation in Drug Discovery
The Many Roles of Computation in Drug DiscoveryThe Many Roles of Computation in Drug Discovery
The Many Roles of Computation in Drug DiscoveryNishoanth Ramanathan
 
Comparability at Molecular level
Comparability at Molecular levelComparability at Molecular level
Comparability at Molecular levelwang1994
 
ArrayBridge(2016)
ArrayBridge(2016)ArrayBridge(2016)
ArrayBridge(2016)Xing Wang
 

Andere mochten auch (20)

Structure based drug design
Structure based drug designStructure based drug design
Structure based drug design
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designing
 
Computer aided drug designing (CADD)
Computer aided drug designing (CADD)Computer aided drug designing (CADD)
Computer aided drug designing (CADD)
 
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERYSTRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
STRUCTURE BASED DRUG DESIGN - MOLECULAR MODELLING AND DRUG DISCOVERY
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
structure based drug design of curcumin analogues
structure based drug design of curcumin analoguesstructure based drug design of curcumin analogues
structure based drug design of curcumin analogues
 
Computer aided drug designing
Computer aided drug designing Computer aided drug designing
Computer aided drug designing
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug design
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
Computer Aided Drug Design and Discovery : An Overview (2006)
Computer Aided Drug Design and Discovery : An Overview (2006)Computer Aided Drug Design and Discovery : An Overview (2006)
Computer Aided Drug Design and Discovery : An Overview (2006)
 
Aiding Computer Aided Drug Design
Aiding Computer Aided Drug DesignAiding Computer Aided Drug Design
Aiding Computer Aided Drug Design
 
Drug design
Drug designDrug design
Drug design
 
Introduction to the drug discovery process
Introduction to the drug discovery processIntroduction to the drug discovery process
Introduction to the drug discovery process
 
Training
TrainingTraining
Training
 
The Many Roles of Computation in Drug Discovery
The Many Roles of Computation in Drug DiscoveryThe Many Roles of Computation in Drug Discovery
The Many Roles of Computation in Drug Discovery
 
Drug design
Drug design Drug design
Drug design
 
Comparability at Molecular level
Comparability at Molecular levelComparability at Molecular level
Comparability at Molecular level
 
ArrayBridge(2016)
ArrayBridge(2016)ArrayBridge(2016)
ArrayBridge(2016)
 
Drug discovery
Drug discoveryDrug discovery
Drug discovery
 

Ähnlich wie Structure based computer aided drug design

Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 
Molecular docking
Molecular dockingMolecular docking
Molecular dockingpalliyath91
 
P. Joshi SBDD and docking.ppt
P. Joshi SBDD and docking.pptP. Joshi SBDD and docking.ppt
P. Joshi SBDD and docking.pptpranalpatilPranal
 
On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...
On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...
On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...Gang Zhang
 
IDENTIFICATION OF PROTEIN BINDING SITE.docx
IDENTIFICATION OF PROTEIN BINDING SITE.docxIDENTIFICATION OF PROTEIN BINDING SITE.docx
IDENTIFICATION OF PROTEIN BINDING SITE.docxSNEHA AGRAWAL GUPTA
 
Igor Segota: PhD thesis presentation
Igor Segota: PhD thesis presentationIgor Segota: PhD thesis presentation
Igor Segota: PhD thesis presentationIgorSegota3
 
Structural Systems Pharmacology
Structural Systems PharmacologyStructural Systems Pharmacology
Structural Systems PharmacologyPhilip Bourne
 
Transcription Mechanism.pdf
Transcription Mechanism.pdfTranscription Mechanism.pdf
Transcription Mechanism.pdfBabita Neupane
 
Electron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein ModelingElectron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein ModelingN. Sukumar
 
The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...
The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...
The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...Haley D. Norman
 
Insight from energy surfaces: structure prediction by lattice energy explora...
Insight from energy surfaces:  structure prediction by lattice energy explora...Insight from energy surfaces:  structure prediction by lattice energy explora...
Insight from energy surfaces: structure prediction by lattice energy explora...GraemeDay
 
Molecular docking
Molecular dockingMolecular docking
Molecular dockingRahul B S
 
Protein Crystallography of Lysozyme
Protein Crystallography of LysozymeProtein Crystallography of Lysozyme
Protein Crystallography of LysozymeGuillermo Llamas
 
Using Calorimetric Data to Drive Accuracy in Computer-Aided Drug Design
Using Calorimetric Data to Drive Accuracy in Computer-Aided Drug DesignUsing Calorimetric Data to Drive Accuracy in Computer-Aided Drug Design
Using Calorimetric Data to Drive Accuracy in Computer-Aided Drug DesignMichael Gilson
 
NMR Random Coil Index & Protein Dynamics
NMR Random Coil Index & Protein Dynamics NMR Random Coil Index & Protein Dynamics
NMR Random Coil Index & Protein Dynamics Mark Berjanskii
 
Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Peter Kenny
 

Ähnlich wie Structure based computer aided drug design (20)

Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
Qsar
QsarQsar
Qsar
 
Molecular docking
Molecular dockingMolecular docking
Molecular docking
 
P. Joshi SBDD and docking.ppt
P. Joshi SBDD and docking.pptP. Joshi SBDD and docking.ppt
P. Joshi SBDD and docking.ppt
 
On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...
On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...
On the All or Half Law of Recombinant DNA, Lentivus Transduction and some oth...
 
IDENTIFICATION OF PROTEIN BINDING SITE.docx
IDENTIFICATION OF PROTEIN BINDING SITE.docxIDENTIFICATION OF PROTEIN BINDING SITE.docx
IDENTIFICATION OF PROTEIN BINDING SITE.docx
 
Igor Segota: PhD thesis presentation
Igor Segota: PhD thesis presentationIgor Segota: PhD thesis presentation
Igor Segota: PhD thesis presentation
 
Structural Systems Pharmacology
Structural Systems PharmacologyStructural Systems Pharmacology
Structural Systems Pharmacology
 
Transcription Mechanism.pdf
Transcription Mechanism.pdfTranscription Mechanism.pdf
Transcription Mechanism.pdf
 
zdockTeaching.ppt
zdockTeaching.pptzdockTeaching.ppt
zdockTeaching.ppt
 
Electron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein ModelingElectron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein Modeling
 
The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...
The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...
The Assembly, Structure and Activation of Influenza a M2 Transmembrane Domain...
 
Insight from energy surfaces: structure prediction by lattice energy explora...
Insight from energy surfaces:  structure prediction by lattice energy explora...Insight from energy surfaces:  structure prediction by lattice energy explora...
Insight from energy surfaces: structure prediction by lattice energy explora...
 
Molecular docking
Molecular dockingMolecular docking
Molecular docking
 
Protein Crystallography of Lysozyme
Protein Crystallography of LysozymeProtein Crystallography of Lysozyme
Protein Crystallography of Lysozyme
 
Protein structure prediction with a focus on Rosetta
Protein structure prediction with a focus on RosettaProtein structure prediction with a focus on Rosetta
Protein structure prediction with a focus on Rosetta
 
Using Calorimetric Data to Drive Accuracy in Computer-Aided Drug Design
Using Calorimetric Data to Drive Accuracy in Computer-Aided Drug DesignUsing Calorimetric Data to Drive Accuracy in Computer-Aided Drug Design
Using Calorimetric Data to Drive Accuracy in Computer-Aided Drug Design
 
10.1.1.80.2149
10.1.1.80.214910.1.1.80.2149
10.1.1.80.2149
 
NMR Random Coil Index & Protein Dynamics
NMR Random Coil Index & Protein Dynamics NMR Random Coil Index & Protein Dynamics
NMR Random Coil Index & Protein Dynamics
 
Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)
 

Kürzlich hochgeladen

This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxNikitaBankoti2
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIShubhangi Sonawane
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 

Kürzlich hochgeladen (20)

This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 

Structure based computer aided drug design

  • 1. Prof. Thanh N. Truong University of Utah Astonis LLC Institute of Computational Science and Technology
  • 2. The Drug Discovery Process Drug Target Identification Target Validation Lead Identification Lead Optimization Pre-clinical & Clinical Development It takes about 15 years and costs around 880 millions USD, ~10,000 compounds (DiMasi et al. 2003; Dickson & Gagnon 2004) to develop a new drug. FDA Review
  • 4. Genomics Facts Around 99% of our genes have counterparts in mice Our genetic overlap with chimpanzees is about 97.5% The genetic difference between one person and another is less than 0.1 % But because only a few regions of DNA actively encode life functions, the real difference between one person and another is only 0.0003 % It is becoming increasingly evident that the complexity of biological systems lies at the level of the proteins, and that genomics alone will not suffice to understand these systems.
  • 5. Structure-based Computer-Aided Drug Design Drug Target Identification Target Validation Shorten development time to Lead Identification Lead Identification Lead Optimization Known 3D structure PDB databank Pre-clinical & Clinical Development FDA Review Unknown 3D structure for the target protein Homology modeling or Protein Structure Prediction Reduce cost MD simulations Past Successes 1. 2. 3. HIV protease inhibitor amprenavir (Agenerase) from Vertex & GSK (Kim et al. 1995) HIV: nelfinavir (Viracept) by Pfizer (& Agouron) (Greer et al. 1994) Influenza neuraminidase inhibitor zanamivir (Relenza) by GSK (Schindler 2000) Target Model Docking Simulation Cluster Analysis Scoring Analysis Trajectories
  • 6. Homology Modeling Prediction of protein tertiary structure from the known sequence
  • 7. Docking The Problem: Determine the optimal binding structure of a ligand (a drug candidate, a small molecule) to a receptor (a drug target, a protein or DNA) and quantify the strength of the ligand-receptor interaction. 1. 2. 3. 4. 5. Where the ligand will bind? How will it bind? How strong? Why? What make a ligand binds to the receptor better than the others? 6. ????
  • 8. The Challenge Ligand and receptor are conformational flexible. Receptor may have more than one possible binding site. Weak short-range Interactions: hydrogen bonds, salt bridges, hydrophobic contacts, electrostatics, van der Walls repulsions Surface complementary. Binding affinity is the difference to the uncomplexed state – solvation and desolvation play important role. Binding affinity describes an ensemble of complexes not a single one. Orientation of Ligand Bound waters Flexibility of residues in the binding site Large protein conformation change
  • 9. Binding Affinity Association equilibrium constant [ RL ]s Ka = [ R ]s [ L ]s b ∆Gg + ∆Gsolv ( R ) ∆Gsolv ( L ) Free energy of binding: b ∆Gs = ∆H − T ∆S = − RT ln K a Enthalpy Entropy + From the thermodynamic cycle: b b ∆Gs = ∆Gg + ∆Gsolv ( RL ) − {∆Gsolv ( R ) + ∆Gsolv ( L )} b ∆Gs ∆Gsolv ( RL )
  • 10. Docking Process Descriptions of the receptor 3D structure, binding site and ligand Sampling of the configuration space of the binding complex Multiple binding configurations for a single protein structure and a ligand Evaluating free energy of binding for scoring Local/global minimum Ensemble of protein structures and/or multiple ligands
  • 11. Description of Receptor 3D Structure Known 3D protein structures from Protein Data Bank (PDB) (http://www.rcsb.org/pdb) Locations of hydrogen atoms, bound water molecules, and metal ions are either not known or highly uncertain. Identities and locations of some heavy atoms (e.g., ~1/6 of N/O of Asn & Gln, and N/C of His incorrectly assigned in PDB; up to 0.5 Å uncertainty in position) Conformational flexibility of proteins is not known Homology models from highly similar sequences with known structures Critical analysis of the receptor structure before docking is needed: resolution, missing residues, bound waters and ions, protonation states, etc.
  • 12. Descriptions of Binding Site Known binding site – PDB database has about 6000 proteinligand complexes Atomistic based o Receptor atomic coordinates and location of a binding box Descriptor based o o o o Surface Volume Points & distances, bond vectors grid and various properties such as electrostatic potential, hydrophobic moment, polar, nonpolar, atom types, etc Unknown binding site Blind docking with the binding box cover the entire receptor – computationally expensive Better method for finding potential binding sites is needed
  • 13. Ligand Chemical Space National Cancer Institute (NCI) public database (http://129.43.27.140/ncidb2/) About 250 K 3D structures ZINC public database (http://zinc.docking.org/) About 8 million 3D structures PubChem public database (http://pubchem.ncbi.nlm.nih.gov/) About 19 million entries (but no 3D structures) Cambridge Structure database (CSD) About 3 million crystal structures Chemical Abstract Service (CAS) and SciFinder Several other smaller databases … Atomic partial charges from MM force fields or MO calculations must be added to each molecule for evaluation of the score function
  • 14. Different Approaches in Docking Complete conformation and configuration space are too large. Different approaches were developed for effective sampling of the receptor-ligand configuration space. Automated Manual Descriptor Matching Simulation-based • Use pattern-recognizing geometric methods to match ligand and receptor site descriptors • Ligand flexibility is limited • Receptor is rigid • Accuracy is not very good – not discriminative • Fast • Use simulation methods to sample the local configuration space: MC-Simulated Annealing, Genetic Algorithm. Must run an ensemble of starting orientations for accurate statistics • Ligand and protein flexibility can be considered • Free energy of binding is evaluated • Accuracy is good • Time consuming • Grid map is often used to speed up energy evaluations User interactive force feedbacks through haptic devices Focus
  • 15. MC-Simulated Annealing Method Randomly change the receptor flexible residues, ligand position, orientation, and/or conformation Evaluate the new energy, Enew YES Enew < Eold ? NO Accept the new move with P = exp{-∆E/kbT} Accept the new move Enew Eold Reduce the temperature NO Naccept or reject > Nlimit YES Done
  • 16. Genetic Algorithm Darwin Theory of Evolution Living organisms Made up of cells Has the same set of chromosomes (DNA) Genome: A set of all chromosomes Chromosome consists of genes Genotype: A particular set of genes Each gene encodes a protein (a trait) Each gene has a location in the chromosome (locus) Reproduction by cross-over and mutation
  • 17. Genetic Algorithm for Docking Gene 1 Gene 2 Gene 3 x1 y1 z1 φ1 ψ1 ω1 τ1 τ2 τ3 τ4 Position Orientation Chromosome 1 Torsional angles x2 y2 z2 φ2 ψ2 ω2 τ1’ τ2’ τ3’ τ4’ Chromosome 2 A chromosome is a possible solution: binding position, orientation, and values of all rotatable torsional angles Fitness Test Translates genotypes to phenotypes (receptor-ligand complex structures) for binding free energy evaluation. A cell is a set of possible solutions, i.e. chromosomes. Typical population = 100-200 Select best parents Those with large negative ∆G binding Generate new generation Migration: Move the best genes to the next generation Cross-over: Exchange a set of genes from one parent chromosome to another. Typical cross-over rate = 80-90% Mutation: Randomly change a value of a gene, i.e. position, orientation, or torsional values. Typical mutation rate = 0.5-1%
  • 18. Two-point Cross-over Operator x1 y1 z1 φ1 ψ1 ω1 τ1 τ2 τ3 τ4 Parent 1 Swap positions x2 y2 z2 φ2 ψ2 ω2 τ1’ τ2’ τ3’ τ4’ Parent 2 x2 y2 z2 φ1 ψ1 ω1 τ1 τ2 τ3 τ4 Child 1 x1 y1 z1 φ2 ψ2 ω2 τ1’ τ2’ τ3’ τ4’ Child 2
  • 19. Lamarkian Genetic Algorithm -- AutoDock Environmental adaptation of an individual’s phenotypic characteristics acquired during lifetime can become heritable traits Survival of the fittest. 1. Mutation and cross-breeding to generate new genotype generate new possible ligand binding configuration 2. Transfer to phenotype to evaluate fitness forming receptor-ligand configuration. Environmental adaption 3. Adapt to the local environment to improve fitness local minimization. 4. Transfer back to genotype for future generations save the optimized ligand binding configuration for future generations. Genetic Algorithm – Local Search Morris et al., J. Comp. Chem. 1998, 19, 1639 Transfer to genotype for future generations, i.e. heritable traits. GA LS
  • 20. Scoring Functions Force Field based function Focus GOAL: Fast & Accurate Experimentally observed complex •Score = -∆Gbinding •Has physical basis •Fast with pre-computed grid Multivariate regression fit physically motivated structural functions to experimentally known complexes with measured binding affinity -Score Empirical function Knowledge-based function Statistical pair potential derived from known complex structures Descriptor based function Based on chemical properties, pharmacaphore, contact, shape complementary Complex configurations
  • 21. Force Field Based Scoring Function b Score = −∆Gs b ∆Gs = Cvdw ∗ ∆Gvdw + Cele ∗ ∆Gele + Chb ∗ ∆Ghb + Ctor ∗ ∆Gtor + Csolv ∗ ∆Gsolv Coefficients are empirically determined using linear regression analysis from a set of protein-ligand complexes from LPDB with known experimental binding constants.
  • 22. Analyses Energy histogram Clustering analysis Distribution of binding energies average binding energy Distribution of binding modes different binding sites and ligand binding orientations
  • 23. Docking with Science Community Laboratory Identify a target Millions of molecules from ZINC database Docking simulation with AutoDock-Vina Rank according to binding energy